Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent ...

Findings provide early evidence supporting potential disease-modifying activity of AP01 (inhaled pirfenidone) in patients ...

AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with ...

Pulmonary fibrosis is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition, ...

A third of patients with connective tissue disease-associated interstitial lung disease developed progressive pulmonary fibrosis.

Inhaled treprostinil may slow the decline in lung function and reduce the risk for disease worsening in patients with ...

The Pulmonary Fibrosis Foundation (PFF) today announced its PFF Walk 2026 schedule as the organization celebrates the 10 (th) season of the national fundraising program, which has raised more than $7.

United Therapeutics Corporation Strong Buy: phase 3 Tyvaso wins in IPF boost FVC, support summer sNDA and Priority Review ...